These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rescuing defective vesicular trafficking protects against alpha-synuclein toxicity in cellular and animal models of Parkinson's disease. Lashuel HA; Hirling H ACS Chem Biol; 2006 Aug; 1(7):420-4. PubMed ID: 17168518 [TBL] [Abstract][Full Text] [Related]
4. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons. Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146 [TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein and tau: teammates in neurodegeneration? Moussaud S; Jones DR; Moussaud-Lamodière EL; Delenclos M; Ross OA; McLean PJ Mol Neurodegener; 2014 Oct; 9():43. PubMed ID: 25352339 [TBL] [Abstract][Full Text] [Related]
6. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Lázaro DF; Dias MC; Carija A; Navarro S; Madaleno CS; Tenreiro S; Ventura S; Outeiro TF Acta Neuropathol Commun; 2016 Dec; 4(1):128. PubMed ID: 27938414 [TBL] [Abstract][Full Text] [Related]
7. PMR1/SPCA Ca2+ pumps and the role of the Golgi apparatus as a Ca2+ store. Wuytack F; Raeymaekers L; Missiaen L Pflugers Arch; 2003 May; 446(2):148-53. PubMed ID: 12739151 [TBL] [Abstract][Full Text] [Related]
8. Protein Partners of α-Synuclein in Health and Disease. Lassen LB; Reimer L; Ferreira N; Betzer C; Jensen PH Brain Pathol; 2016 May; 26(3):389-97. PubMed ID: 26940507 [TBL] [Abstract][Full Text] [Related]
9. Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders? Windisch M; Wolf HJ; Hutter-Paier B; Hofmeister A; Wronski R Curr Alzheimer Res; 2007 Sep; 4(4):446-57. PubMed ID: 17908049 [TBL] [Abstract][Full Text] [Related]